Health in Senegal

1,204 indicators covering health for Senegal.

IndicatorLatest Year10-yr change Rank
Tuberculosis treatment success rate in new and relapsed cases 89 2023 up 2.3% 59th
Share of public expenditure on healthcare by country 27.57 2023 up 3.3% 160th
Private health expenditure per person 114.38 2023 up 47.4% 146th
Public healthcare spending share gdp 1.19 2023 up 1.8% 160th
Health spending per person by source 56.69 2023 up 74.9% 157th
Poliomyelitis - number of reported cases 0 2018 β€” 8th
Number of new hiv infections per year 2,978 2024 up 89.0% 48th
Rubella vaccination coverage 87 2024 up 8.8% 121st
Deaths from aids un 965.62 2024 down 48.3% 54th
Mortality rate among children ages 10 to 14 years 4.01 2020 down 46.7% 38th
Cost healthy diet 3.73 2024 up 40.8% 136th
Terrorism deaths by region 0 2021 down 100.0% 58th
Medical doctors 2,289 2024 up 98.4% 131st
Adults (ages 15-49) newly infected with HIV 2,600 2024 up 136.4% 44th
People with basic handwashing facilities including soap and water 26.9% 2024 up 36.8% 91st
Number of new hiv child infections vs number of infections averted due 312.86 2024 up 11.3% 38th
Mean systolic blood pressure 128.6 2015 down 0.5% 27th
UHC Service Coverage sub-index on infectious diseases 54 2023 up 10.2% 149th
UHC Service Coverage sub-index on service capacity and access 26 2023 up 36.8% 179th
UHC Service Coverage sub-index on reproductive, maternal, newborn and 55 2023 up 7.8% 161st
UHC Service Coverage Index 48 2023 up 14.3% 162nd
UHC Service Coverage sub-index on noncommunicable diseases 70 2023 up 9.4% 34th
Stillbirth rate 18.03 2023 down 14.9% 37th
Number of stillbirths 9,764 2023 down 10.5% 38th
Hepb3 number unvaccinated 39,752 2023 up 6.5% 66th
Rotavirus vaccines completed dose (RotaC) immunization coverage among 90.0% 2025 up 8.4% 32nd
Young people (ages 15-24) newly infected with HIV 500 2024 unchanged 55th
Tb related deaths hiv 160 2023 down 54.3% 61st
Smoking bans in public places 7 2022 up 250.0% 75th
Current health expenditure (CHE) as percentage of gross domestic produ 4.3% 2023 down 1.4% 147th
External health expenditure (EXT) as percentage of current health expe 16.8% 2023 up 78.3% 44th
Domestic general government health expenditure (GGHE-D) as percentage 27.6% 2023 up 3.3% 161st
Out-of-pocket expenditure as percentage of current health expenditure 44.3% 2023 down 19.8% 47th
Domestic general government health expenditure (GGHE-D) as percentage 1.2% 2023 up 1.8% 161st
Domestic general government health expenditure (GGHE-D) as percentage 3.6% 2023 down 32.6% 184th
Domestic private health expenditure (PVT-D) as percentage of current h 55.6% 2023 down 12.9% 36th
Current health expenditure (CHE) per capita in US$ 73.23 2023 up 21.0% 160th
Domestic private health expenditure (PVT-D) per capita in US$ 40.73 2023 up 5.4% 148th
Domestic general government health expenditure (GGHE-D) per capita in 20.19 2023 up 25.0% 160th
Total healthcare expenditure gdp 4.32 2023 down 1.4% 148th
Health expenditure government expenditure 3.57 2023 down 32.6% 185th
Mumps - number of reported cases 12,475 2025 up 18,519.4% 6th
Incidence of tuberculosis (per 100 000 population) 4.3 2023 down 57.0% 64th
Hib vaccine 91 2024 up 2.2% 91st
External health expenditure (EXT) per capita in US$ 12.3 2023 up 115.7% 57th
Dentists 200 2024 up 65.3% 126th
People with basic handwashing facilities including soap and water, rur 20.5% 2024 up 280.3% 84th
Nursing and midwifery personnel 7,988 2024 up 77.8% 133rd
Nursing personnel 5,033 2024 up 102.1% 140th
People using safely managed drinking water services, rural 13.2% 2024 up 23.2% 70th
Raised blood pressure (SBP>=140 OR DBP>=90) 36.64 2019 down 7.6% 41st
Raised blood pressure (SBP>=140 OR DBP>=90) 33.1 2019 down 8.6% 63rd
Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 38.6% 2019 up 53.2% 165th
Hypertension among adults aged 30-79 years, prevalence, age-standardiz 40.5 2019 down 2.6% 72nd
Hypertension effective treatment coverage (controlled hypertension )am 9.5% 2019 up 106.5% 159th
Hypertension: effective treatment coverage (controlled hypertension) a 9.0% 2019 up 95.7% 161st
Hypertension treatment coverage among adults aged 30-79 with hypertens 19.8% 2019 up 47.8% 173rd
Hypertension treatment coverage among adults aged 30-79 with hypertens 21.2% 2019 up 49.3% 172nd
Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 36.2% 2019 up 52.7% 166th
Hypertension among adults aged 30-79 years, prevalence, crude 36.4 2019 down 4.2% 101st